Sadhana Nitrochem Reports No Deviation in Rights Issue Proceeds Utilization
Sadhana Nitrochem Limited confirms no deviation in the utilization of ₹263.53 Crores raised via Rights Issue on March 12, 2026. For the quarter ended March 31, 2026, ₹251.95 Crores were utilized across various purposes including Inter-Corporate Deposit and Promoters Loan.
This is a standard regulatory filing to confirm adherence to the utilization plan of funds raised through a Rights Issue. It does not introduce any new information that would significantly impact the company's operations or stock.
The announcement is a routine compliance filing confirming no deviation in fund utilization. It does not contain any new positive or negative developments.
Sadhana Nitrochem Limited has submitted a statement to BSE Limited and the National Stock Exchange of India Limited confirming no deviation or variation in the utilization of proceeds raised through its Rights Issue. The funds, amounting to ₹263.53 Crores and raised on March 12, 2026, were intended for various purposes including Inter-Corporate Deposit, Promoters Loan, Term Loan, Long-Term Working Capital, General Corporate Purposes, and Issue Related expenses.
For the quarter ended March 31, 2026, the company reported that the utilized amount was ₹251.95 Crores. Specifically, ₹129.09 Crores were utilized for Inter-Corporate Deposit, ₹80.76 Crores for Promoters Loan, ₹6.04 Crores for Term Loan, ₹12.05 Crores for Long-Term Working Capital, ₹22.73 Crores for General Corporate Purposes, and ₹1.28 Crores for Issue Related expenses. The statement, duly reviewed by the Audit Committee, confirms that there were no deviations from the original allocation or utilization plan for these funds.
The company, with Abhishek Asit Javeri as the Managing Director, confirmed that the report was prepared in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Acuite Ratings and Research Limited was appointed as the monitoring agency for the issue.
What to do with a filing like this
Sadhana Nitrochem Limited filed this with the NSE as a statutory disclosure, categorised under debt fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sadhana Nitrochem Limited. Read the original for the full detail.